Latest Breaking News On - Ashlee dunston - Page 1 : comparemela.com

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Ashlee dunstonAtyr pharma incCompensation committeePublic affairsTyr pharmaNasdaq capital marketNasdaq listing ruleInvestor relations

ATyr Pharma to Participate in April Investor Conferences

SAN DIEGO, April 01, 2024 aTyr Pharma, Inc. , a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase.

Piper sandlerAshlee dunstonPublic affairsAtyr pharma incGlobenewswire incTyr pharmaRough webinarCorporate presentationPiper sandler spring biopharmaInvestor relations

ATyr Pharma Announces Howard University President Emeritus Dr Wayne A I Frederick as Advisor

SAN DIEGO, Jan. 18, 2024 aTyr Pharma, Inc. , a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase.

United statesAshlee dunstonWayneai frederickSanjays shuklaDepartment of surgeryInsulet corporationNational academy of medicineGlobenewswire incHoward university college of medicineHoward universitySchool of businessHoward university hospitalMutual of america life insurance coPublic affairsAmerican surgical associationWorkday inc

aTyr Pharma to Present at November Investor Conferences

01.11.2023 - SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) - aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today .

United kingdomCity ofNew yorkUnited statesPiper sandlerAshlee dunstonPublic affairsJefferies london healthcareCorporate presentationAnnual healthcareFireside chatInvestor relations

aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD

aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAshlee dunstonSanjays shuklaPublic affairsEuropean unionRheumatic lung disease programDrug administrationAtyr pharma incTyr pharmaChief executive officerKristin highlandPrivate securities litigation reform actAnnual reportQuarterly reportInvestor relations